Skip to main content

Hudson Bay Capital Management LP

Position in LKFT — Lakefront Biotherapeutics NV

CIK 1393825 STAMFORD, CT

Position in LKFT

as of Mar 31, 2026 · filed May 13, 2026
Position Value
$2,325,000
-$3,234,000 QoQ
Shares Held
77,500
-54.4% QoQ
Ownership
0.118%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2021
21 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in LKFT Over Time

Shares Held

Position Value (USD)

Derivatives in LKFT

reported options exposure · as of Jun 30, 2025
CallValue
$7,932,366
CallShares
283,400
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Hudson Bay Capital Management LP holds $565,779,637 across 77 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in LKFT

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $2,325,000 77,500
2025-12-31 $5,559,000 170,000
2025-09-30 $8,486,800 245,000
2025-06-30 $14,414,850 515,000
2025-06-30 $7,932,366 283,400
2025-03-31 $14,192,800 565,000
2024-12-31 $15,243,250 554,300
2024-09-30 $14,682,900 510,000
2024-06-30 $13,009,500 525,000
2024-03-31 $13,923,280 432,400
2023-12-31 $13,495,800 332,000
2023-09-30 $12,092,500 350,000
2023-06-30 $13,214,500 325,000
2023-03-31 $8,733,412 226,020
2022-12-31 $13,868,750 312,500
2022-09-30 $13,751,400 322,500
2022-06-30 $12,080,700 216,500
2022-03-31 $2,015,650 32,500
2021-12-31 $7,993,850 145,000
2021-09-30 $8,154,550 155,000
2021-06-30 $8,611,250 125,000
2021-03-31 $4,432,675 57,500